Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatocellular carcinoma
(
HCC
) is reported to associate with abnormal expression of SCF E3 ubiquitin ligases.
FBXW10
, an F-box protein of the E3 ubiquitin ligases, was abnormally regulated in
HCC
patients. However, whether
FBXW10
is associated with
HCC
has not yet been evaluated. Here, we analyzed the associations between overall survival and various risk factors in 191
HCC
tissues. Univariate and multivariate analyses demonstrated that
FBXW10
was an independent risk factor related to
HCC
prognosis. The results showed that
FBXW10
, gender and tumor state were strongly associated with overall survival in
HCC
patients. Furthermore, high expression of
FBXW10
was associated with poor survival among male
HCC
patients but not female
HCC
patients.
FBXW10
was more highly expressed in male
HCC
tissues and more strongly related to vascular invasion in male
HCC
patients. Consistent with these findings, the male
FBXW10
-Tg(+) mice were more susceptible to tumorigenesis, changes in regenerative capacity, and liver injury and inflammation but not changes in liver function than
FBXW10
-Tg(-) mice.
FBXW10
promoted cell proliferation and migration in
HCC
cell lines. Our findings reveal that
FBXW10
, an independent risk factor for
HCC
, promotes hepatocarcinogenesis in male patients, and is also a potential prognostic marker in male patients with
HCC
.
...
PMID:FBXW10 promotes hepatocarcinogenesis in male patients and mice. 3140 Jul 58